These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Identification of RBPMS as a mammalian smooth muscle master splicing regulator via proximity of its gene with super-enhancers. Nakagaki-Silva EE; Gooding C; Llorian M; Jacob AG; Richards F; Buckroyd A; Sinha S; Smith CWJ Elife; 2019 Jul; 8():. PubMed ID: 31283468 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. Lemire JM; Chan CK; Bressler S; Miller J; LeBaron RG; Wight TN J Cell Biochem; 2007 Jun; 101(3):753-66. PubMed ID: 17226775 [TBL] [Abstract][Full Text] [Related]
11. Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs. Keire PA; L'Heureux N; Vernon RB; Merrilees MJ; Starcher B; Okon E; Dusserre N; McAllister TN; Wight TN Tissue Eng Part A; 2010 Feb; 16(2):501-12. PubMed ID: 19712046 [TBL] [Abstract][Full Text] [Related]
12. Lp3/Hapln3, a novel link protein that co-localizes with versican and is coordinately up-regulated by platelet-derived growth factor in arterial smooth muscle cells. Ogawa H; Oohashi T; Sata M; Bekku Y; Hirohata S; Nakamura K; Yonezawa T; Kusachi S; Shiratori Y; Ninomiya Y Matrix Biol; 2004 Aug; 23(5):287-98. PubMed ID: 15464361 [TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival. Ekstrand J; Razuvaev A; Folkersen L; Roy J; Hedin U J Vasc Surg; 2010 Jul; 52(1):167-75. PubMed ID: 20537494 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways. Cardoso LE; Little PJ; Ballinger ML; Chan CK; Braun KR; Potter-Perigo S; Bornfeldt KE; Kinsella MG; Wight TN J Biol Chem; 2010 Mar; 285(10):6987-95. PubMed ID: 20042606 [TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway. Huang C; Zhang W; Zhu Y Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560 [TBL] [Abstract][Full Text] [Related]
17. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation. Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796 [TBL] [Abstract][Full Text] [Related]
18. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients. Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451 [TBL] [Abstract][Full Text] [Related]